Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer.

The local growth of tumors and their ability to metastasize are crucially dependent on their interactions with the surrounding extracellular matrix. Tenascin-C (TNC) is an extracellular matrix protein which is highly expressed during development, tissue repair and cancer. Despite the high levels of TNC in the stroma of primary and metastatic tumors, the function of TNC is not known. In the present study we have crossed TNC-null mice with a mouse strain where both female and male mice spontaneously develop mammary tumors followed by metastatic disease in the lungs. We report that the absence of TNC had no effect on the temporal occurrence of mammary tumors and their metastatic dissemination in lungs. Furthermore, the number and size of tumors, the number and size of metastatic foci in the lungs, the proliferation rate and apoptosis of tumor cells and tumor angiogenesis were not altered in the absence of TNC. Histological examination revealed that the tumor organisation, however, was modulated by TNC. In the presence of TNC both primary as well as metastatic tumors were organised in large tumor cell nests surrounded by thick layers of extracellular matrix proteins. In the absence of TNC these tumor cell nests were smaller but still separated from each other by extracellular matrix proteins. In addition, the TNC-null stromal compartment contained significantly more monocytes/macrophages than tumor stroma from TNC wild-type mice. Using in vitro coculture experiments we show that TNC-null tumor cells were still able to activate the TNC gene in fibroblasts which express low basal levels of TNC. Altogether these data indicate that TNC has a very limited role during the spontaneous development and growth of mamary tumors and their metastasis to the lungs.

[1]  Ernst Hunziker,et al.  Collagen II Is Essential for the Removal of the Notochord and the Formation of Intervertebral Discs , 1998, The Journal of cell biology.

[2]  J. Talts,et al.  Expansion of the nonadherent myeloid cell population by monoclonal antibodies against tenascin-C in murine long-term bone marrow cultures. , 1998, Experimental hematology.

[3]  S. Aizawa,et al.  Suppression of hematopoietic activity in tenascin-C-deficient mice. , 1998, Blood.

[4]  E. Mackie Molecules in focus: tenascin-C. , 1997, The international journal of biochemistry & cell biology.

[5]  N. Wernert The multiple roles of tumour stroma , 1997, Virchows Archiv.

[6]  H. Eng,et al.  Characterization of monoclonal antibodies against tenascin-C: no apparent effect on kidney development in vitro. , 1997, The International journal of developmental biology.

[7]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[8]  S. Werner,et al.  Skin wounds and severed nerves heal normally in mice lacking tenascin-C. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Deryugina,et al.  Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. , 1996, Journal of cell science.

[10]  E. Spiess,et al.  Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons , 1996, The Journal of cell biology.

[11]  T. Sasaki,et al.  Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. , 1996, Experimental cell research.

[12]  H. Erickson,et al.  Binding of Tenascin-C to Soluble Fibronectin and Matrix Fibrils * , 1995, The Journal of Biological Chemistry.

[13]  M. Hermann,et al.  Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation. , 1995, Journal of cell science.

[14]  R. Timpl,et al.  Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma. , 1995, Journal of cell science.

[15]  D. Miller,et al.  Tenascin expression in astrocytomas correlates with angiogenesis. , 1995, Cancer research.

[16]  A. Canfield,et al.  Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. , 1995, Journal of cell science.

[17]  A. Irintchev,et al.  Polyclonal antibodies against NCAM and tenascin delay endplate reinnervation , 1994, Journal of neurocytology.

[18]  D. Taverna,et al.  Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation. , 1994, Journal of cell science.

[19]  T. Sasaki,et al.  Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding , 1993, The Journal of cell biology.

[20]  R. Fässler,et al.  Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts , 1993, The Journal of cell biology.

[21]  G. Ocklind,et al.  Induction of mouse tenascin expression by a human sarcomatoid wilms' tumor cell line growing in nude mice , 1993, International journal of cancer.

[22]  Y Ikawa,et al.  Mice develop normally without tenascin. , 1992, Genes & development.

[23]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[24]  N. Jing,et al.  Murine tenascin: cDNA cloning, structure and temporal expression of isoforms. , 1991, Gene.

[25]  A. Bhattacharyya,et al.  Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. , 1991, Human pathology.

[26]  László Patthy,et al.  Exons – original building blocks of proteins? , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.

[27]  L. Zardi,et al.  Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues , 1991, International journal of cancer.

[28]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[29]  P. Ekblom,et al.  Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis , 1991, The Journal of cell biology.

[30]  C. Rüegg,et al.  Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  B. Groner,et al.  New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally , 1989, The Journal of cell biology.

[32]  W. Halfter,et al.  Induction of tenascin in healing wounds , 1988, The Journal of cell biology.

[33]  R. Timpl,et al.  Characterization of proteolytic fragments of the laminin-nidogen complex and their activity in ligand-binding assays. , 1988, European journal of biochemistry.

[34]  M. Kusakabe,et al.  Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. , 1988, Developmental biology.

[35]  G. Wirl,et al.  Collagen-binding proteins of rat mammary tumor epithelial cells: a biochemical and immunological study. , 1988, Experimental cell research.

[36]  R. Chiquet‐Ehrismann,et al.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis , 1986, Cell.

[37]  V. Perry,et al.  The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: Macrophages associated with epithelia , 1984, The Anatomical record.

[38]  H. Erickson,et al.  A six-armed oligomer isolated from cell surface fibronectin preparations , 1984, Nature.

[39]  M. Chiquet,et al.  Chick myotendinous antigen. II. A novel extracellular glycoprotein complex consisting of large disulfide-linked subunits , 1984, The Journal of cell biology.

[40]  D. Hume,et al.  The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs , 1983, The Journal of experimental medicine.

[41]  D. Bigner,et al.  Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. , 1983, Cancer research.

[42]  R. Treisman,et al.  Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein , 1981, Nature.

[43]  D. Zagzag,et al.  Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. , 1996, Cancer research.

[44]  G. Edelman,et al.  Separate cell binding sites within cytotactin/tenascin differentially promote neurite outgrowth. , 1995, Cell adhesion and communication.

[45]  A. Faissner,et al.  Tenascin glycoproteins in developing neural tissues: only decoration? , 1994, Perspectives on developmental neurobiology.

[46]  T. Hsu,et al.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Hogan,et al.  Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. , 1990, Current topics in developmental biology.

[48]  H. Erickson,et al.  Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. , 1989, Annual review of cell biology.

[49]  A. van den Hooff Stromal involvement in malignant growth. , 1988, Advances in cancer research.

[50]  A. van den Hooff,et al.  Stromal involvement in malignant growth. , 1988 .